Key Takeaways
- Soft quarter, in-line guide kept: Revenue declined 1.6% QoQ in constant currency, better than management expected, and full-year revenue (3–5%) and margin (18–19%) guidance was reaffirmed.
- Manufacturing and ER&D drove the miss: An unexpected $20 mn revenue drop in Engineering R&D, concentrated in Automotive and Med-Tech, pulled down both the top line and Services margin by 51 bps.
- GenAI is the investment thesis, not yet the growth engine: Activity in AI Labs and platform launches is high, but management sees GenAI as an eventual incremental positive that will create a new spend trajectory, not a near-term revenue accelerator.
- State Street exit masks underlying headcount stability: Headcount fell 3.6% QoQ almost entirely on the JV divestment; the firm still plans to hire 10,000 freshers this fiscal and is training 50,000 people on GenAI.
- What to watch next quarter: Whether Manufacturing and ER&D margins recover as promised, the size of the State Street revenue step-down in Financial Services, and any signal on wage hike timing.
Revenue Walk: What Drove the Q1 Decline
- Seasonal softness, better than feared: Q1 is always HCLTech's softest quarter; the 1.6% sequential constant-currency decline was ahead of the internal plan set three months earlier.
- Manufacturing vertical collapsed on three fronts: Traditional year-on-year productivity that kicks in April hit Manufacturing hardest; Automotive firms in Europe, under their own stress, ramped down projects sharply; and asset revenue fell roughly $10 mn, all in Manufacturing.
- ASAP acquisition underperformed: The acquired ER&D asset did not deliver as expected in Q1 because large automotive clients with significant software capability cut spending, and EV-market softening led to deprioritized investments.
- Life Sciences & Healthcare fell on project completions: The 4.1% YoY decline came from projects that ended last year plus softness in the mid-tech segment.
- Tech & Services showed green shoots: Programs won two to three quarters ago began contributing, and hyperscaler infrastructure work provided momentum, though Engineering Services within the vertical did not yet contribute meaningfully.
Vijayakumar: "Second, we saw in fact a significant weakness in the Automotive segment, contrary to all the expectations, because we see a lot of stress with the"
Vertical & Segment Performance
| Vertical / Segment | Trend | Commentary |
|---|---|---|
| Manufacturing | ▼ Sharp decline | Automotive stress in Europe, EV deprioritization, annual productivity impact, and ASAP miss all concentrated here. |
| Life Sciences & Healthcare | ▼ Declined | Project completions and mid-tech softness drove a 4.1% YoY drop. |
| Engineering R&D | ▼ Declined | $20 mn revenue drop with flat costs; decline was unexpected during the quarter, leaving no time for corrective action. |
| Financial Services | ▬ Flat (pre-exit) | Discretionary spend not picking up; Q2 will carry additional State Street divestiture impact before big wins start contributing in Q3 and Q4. |
| Tech & Services | ▲ Improving | Digital programs and hyperscaler infrastructure work driving growth; Engineering Services contribution still a hope for next quarter. |
| Services margin | ▼ –51 bps QoQ | Entirely driven by the ER&D revenue decline percolating to margins. |
- Demand environment unchanged: The going-in assumption for the year was discretionary spend similar to last year, and nothing in Q1 changed that view enough to project optimism.
- Q2 growth expected broadly: Management expects sequential growth in all verticals and geographies except Financial Services, where the State Street exit will create one more quarter of planned revenue impact.
GenAI: Activity, Platforms, and the Productivity Question
- Full-stack proposition driving activity: HCLTech is pitching GenAI across business processes, product applications, data, cognitive infrastructure, and semiconductor design, with AI Labs providing strategic advisory through ideate-to-MVP experiences.
- Platform launches accelerated: HCLTech AI Force (integrating the DRYiCE suite for generative-AI-driven runbook creation) and HCLTech Enterprise AI Foundry (data innovation for enterprise AI) both launched in the quarter.
- Software portfolio fully infused: Every major product in the HCL Software portfolio now has embedded GenAI capabilities.
- Infrastructure build-out: A GenAI-dedicated data center opened in Austin, Texas, and a GenAI Center of Excellence with IBM was announced, based on the Watson X AI data platform.
- Competitive intensity is driving irrational behavior: Management sees competitors making uneconomic GenAI promises, creating pricing pressure that is not client-driven but competitor-driven.
- Productivity pass-through framework: Per management's own framework, GenAI can deliver roughly 50% savings in DPO/testing, 10–30% in ADM, and 10% in infrastructure operations, though even the most advanced companies target only 10% on software development internally.
- GenAI as incremental, not replacement: Management believes GenAI will eventually create a new spend trajectory, analogous to how cloud grew incrementally, but did not quantify what portion of current GenAI work is incremental versus replacing other projects.
Vijayakumar: "I personally think it will create a new spend trajectory."
Margins: The ER&D Shock and the Recovery Path
- Services margin fell 51 bps QoQ: The entire decline traces to the Engineering R&D segment, where a $20 mn revenue drop hit with costs held flat, leaving no time for corrective action within the quarter.
- Seasonal margin pattern intact: Q1 is typically the softest EBIT quarter; Q2 picks up; Q3 is the peak; Q4 lands in the middle. Management expects that pattern to hold this year.
- Full-year EBIT guidance of 18–19% reaffirmed: Despite the Q1 miss, the band is unchanged, implying a steep recovery through the remaining three quarters.
- ER&D margins expected to recover quickly: Corrective action is underway during the current quarter, and management hopes to see some growth resume.
- Wage hike timing unresolved: When asked about the planned hike and the operating levers to stay within the 18–19% band, management declined to speculate, calling the decision a work in progress.
Capital Allocation & Corporate Actions
- State Street DPO JV divestment completed: The exit closed in Q1, driving the 3.6% headcount reduction and creating an accounting divergence between USD and rupee net income through other income.
- Dividend declared: The board declared ₹12 per share as an interim dividend, with a 23 July record date and 1 August payment.
- Acquisition not in guidance: A deal announced in May 2024 will take another 6–9 months to close and is excluded from the organic revenue and margin guidance.
- Investor Day scheduled: Planned for 28 August in Mumbai.
People & Talent
- Headcount drop is optical: The 3.6% sequential decline is largely attributed to the State Street JV exit, not underlying demand weakness.
- Fresher hiring plan intact: Full-year target of 10,000; 1,100 added in Q1, with off-campus hiring providing flexibility to moderate the pace quarter by quarter to match demand.
- GenAI training at scale: Target of training 50,000 people on GenAI and AI skills this fiscal year.
- New center in Patna: Opened as part of the continuing new Vista strategy to expand into tier-2 cities.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Full-year revenue growth | 3% to 5% in constant currency | FY25 |
| Full-year EBIT margin | 18% to 19% | FY25 |
| Sequential growth | All verticals and geographies except Financial Services | Q2 FY25 |
| Financial Services recovery | Growth to resume after State Street impact ends | Q3 and Q4 FY25 |
| ER&D margin recovery | Most of the Q1 decline recovered via corrective action | Q2 FY25 |
| Fresher hiring | 10,000 for the full year | FY25 |
| GenAI training | 50,000 people trained | FY25 |
| Acquisition close | Deal announced May 2024 to close | 6–9 months from Q1 |
Key Metrics
| Metric | Q1 FY25 |
|---|---|
| Revenue | $3.364 bn, -1.6% QoQ and +5.6% YoY in constant currency |
| Services revenue | $3,041 mn, -1.9% QoQ and +5.8% YoY in constant currency |
| IT & Business Services revenue | $2.5 bn, -1.5% QoQ and +5.3% YoY in constant currency |
| Engineering & R&D Services revenue | -3.5% QoQ and +8.4% YoY in constant currency |
| HCL Software revenue | +0.4% QoQ and +3.5% YoY in constant currency; ARR at $1.01 bn |
| EBIT | $575 mn at 17.1%, -50 bps QoQ and +13 bps YoY |
| Net income (USD) | $496 mn at 14.7%, +3.4% QoQ and +15.3% YoY |
| Net income (INR, IndAS) | 15.2%, divergence of ~43 bps from USD net income due to State Street JV divestiture accounting |
| Revenue guidance (FY25) | 3% to 5% constant currency, unchanged |
| EBIT guidance (FY25) | 18% to 19%, unchanged |
| Large-deal TCV | $1.96 bn |
| Total headcount | 219,401, -3.6% QoQ largely due to State Street JV exit |
| IT services voluntary attrition (LTM) | 12.8% |
| Services ROIC (LTM) | 42.8%, +4.8 ppt YoY |
| Company ROIC (LTM) | 34.6%, +3.5 ppt YoY |
| Operating cash flow (LTM) | ₹270 cr, +9% YoY; 139% conversion vs net income |
| Free cash flow (LTM) | ₹260 cr, +12% YoY; 133% conversion vs net income |
| Net cash | $2,985 mn |
| Diluted EPS (LTM) | ₹60.52, +8.7% YoY |
| Interim dividend | ₹12 per share, record date 23 July, payment 1 August |
| Fresher hiring plan (FY25) | 10,000; 1,100 added in Q1 |
| GenAI training target (FY25) | 50,000 people; 33% achieved in Q1 |